Rayno Biobeat #1… Hot Biotech Stocks: Searching for Clues in a Chaotic Market
Rayno Life Science... Special Report #1: Hot Biotech Stocks in 2016 Biotech stocks have been in a funk for most of 2016 and then got absolutely crushed in October. The underlying causes are well-known among them bad news from bad actors like Mylan and Turing, the populist revolt against high...
Biotech Meltdown: Financial Metrics Offer Few Clues For What is Next
Biotech Meltdown: Numbers Don't Mean Much Until We See New Product Growth We are almost through the earnings season and despite good results most biotech stocks tanked again today.The reason you know well by now-expectations for earnings and top line growth have been taken down because price...
Biotech Bear Market Looking For Relief From Q3 Large Cap Growth…Update-3
Update-3... 10/28 9:30 am... No Relief From Earnings- Biotech Stocks Get Crushed By More Pricing Commentary on Earnings Calls Amgen (AMGN) down 11% on pipeline, revenue growth, Enbrel pricing concerns despite beat. Softer pricing environment from McKesson (MCK). All large caps are red except...
BIO Investor Forum 2016 #2:”Liquid Biopsy” Tests for Cancer…Update-1
CLIA Labs Offer Liquid Biopsy Tests for Cancer and Precision Medicine We attended presentations from two emerging companies developing molecular diagnostics platforms focused in cancer.Their mission is to develop cost-effective, non-invasive diagnostic assays and biomarkers directly from blood...
BIO Investor Forum 2016 #1: Translating Microbiome Research Into Treatments
Microbiomes: A New Paradigm for Drug Discovery? Focus: Drugs From Gut Bacteria You may have read a few articles about the impact of the microbiomes and their impact on diets, digestion and nutrition but now there is the potential of discovering new therapies from bacteria in your gut. We are...